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Background: To screen the newborn by Transient evoked Otoacoustic emission and to assess the incidence of
hearing damage and associated risk factors.
Method: This longitudinal prospective observational study was conducted at a tertiary care hospital in India. A total
of 415 babies were included in the study. All the newborns were evaluated with Transient evoked Otoacoustic
emission (TEOAE) which was done by age of 1–3 days. Auditory brain stem response audiometry (AABR) was
performed at the age of three months for confirming the hearing loss in the neonates those who failed the TEOAE
screening. For infants proven to have significant hearing loss in one or both ears, were denoted to an ear, nose,
and throat specialist for further evaluation & rehabilitation.
Results: Out of total 415 babies included in the study, 22 neonates showed abnormal TEOAE examination. Out of
these 22 neonates, hearing loss was confirmed in 18 (82 %) subjects. by AABR. The following antenatal and post-natal
risk factors were associated with hearing loss: ante-partum bleeding, history of maternal blood transfusion, fetal distress,
prematurity, severe birth asphyxia, NICU admission for more than 24 h and Apgar score less than five at 5 min.
Conclusion: Late identification of hearing loss presents a substantial public health burden. Early recognition and
intervention prior to 6 months of age has a significant positive impact on development. A high incidence of hearing
impairment seen in our study neonatal population warrants the urgent implementation of universal hearing screening
of all the newborn infants in India. NICU infants admitted for more than 24 h are to have an auditory brainstem
response (AABR) included as part of their screening so that neural hearing loss will not be missed.
Keywords: Transient evoked Otoacoustic emission (TEOAE), Auditory brain stem response audiometry (AABR),
Newborn screening, Hearing impairment risk factorBackground
Hearing impairment has a devastating, and detrimental
impact on the development of newborn infants [1]. Neo-
nates having bilateral hearing loss or unilateral hearing
loss of varying degrees above 1000 Hz develop signifi-
cant long term effects on speech and language sciences
[2]. Reduced auditory input also adversely affects growth
of the auditory nervous system, and can negatively affect
the speech perception that interferes with the increment
in social, emotional, behavioral, and cognitive spheres,
academic achievement, vocational alternatives, employ-
ment, and economic self-sufficiency [3]. The major diffi-
culty with late identification of hearing loss is the effect* Correspondence: dr.deepak.rohtak@gmail.com
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mean a delay in establishing effective communication.
Professionals agree that hearing loss in infants should be
detected promptlyand appropriate audiologic rehabilita-
tion should be instituted early, to take advantage of the
plasticity of developing the sensory system (critical
period is 0–3 years). This exploit can lead to normal
speech and speech development, social, emotional, and
cognitive development, and academic achievement in
the youngster [4, 5]. In addition, identifying hearing loss
before it is clinically apparent, provides a baseline on
which subsequent evaluation can be developed and com-
pared. Also, medical, and surgical treatment can be initi-
ated for conductive hearing loss to limit its progression.
Timely information also provides the acceptance of
hearing damage and improves the parent’s readiness tohis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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many parts of the world routine newborn hearing screen-
ing has been implemented with varied success [7–13], but
in developing world nations like ours universal screening
is not available and has many obstacles to its implemena-
tion [14, 15]. In India, there is no dedicated national pro-
gram for early detection of hearing loss in newborns.
Studies suggest that four out of every 1000 neonates have
severe to profound hearing loss [16, 17].
The present study was designed to perform newborn
hearing by Otoacoustic emission (TEOAE), determine
the incidence of hearing damage in a population of at
risk and not at risk neonates, and to determine various
risk factor associations with learning impairment.
Methods
We conducted a prospective observational longitudinal
study in a tertiary care hospital in India, Department of
Pediatrics, Sardar Patel Medical College, & Associated
Group of Hospitals, Bikaner (Rajasthan). The study was
approved by institutional research board (IRB) of the
college.
During the 8 month study period, form March, 2011 to
October 2011, a total 1125 neonates were born in our hos-
pital. We decided to enroll 415 neonates in the study. All
the neonates born during the study period were divided
into neonates with and without risk factors using predeter-
mined Joint Committee statement on infant hearing
screening (JCIH) criteria. Then each neonate was given a
sequential number and enrolled in the study using random
numbers generated by the computer for each group and
enrolled till our sample size reached 415.
Inclusion criteria
All newborn babies born in our hospital from 3/11-10/11.
Exclusion criteria
Fail to get parental consent
Out of total 248 newborns having no risk factor while
167 newborn had some risk factor for hearing loss as
per American Joint Committee statement on infant
hearing screening (JCIH) criteria [18]. The risk factors
which were assessed included
1. Low birth weight (less than 2 lb) and/or prematurity.
2. Assisted ventilation (to aid with breathing for more
than 10 days after parturition).
3. Low Apgar scores with severe birth asphyxia (defined
as Apgar score of three or less at 1 min of age).
4. Severe jaundice after birth requiring exchange
transfusion or serum bilirubin level >20 mg/decilitre.
5. Hydrocephalus
6. Maternal illness during pregnancy (for example,
German measles [Rubella]).7. An illness or condition requiring admission of 24 h
or more to a NICU.
8. Stigmata or other findings associated with a known
syndrome to include a sensorineural and/or
conductive hearing loss.
9. Family history of permanent childhood sensorineural
hearing loss.
10. Craniofacial anomalies including those with
morphological abnormalities of the pinna & ear canal.
11. In utero infection by TORCH group of organisms.
12. Respiratory distress;(presence of at least two of the
following criteria-respiratory rate more than 60 per
minute/subcostal or intercostal recession/expiratory
grunt or groaning).
13. Meningitis and sepsis with positive CSF and blood
cultures respectively.
14. Parental concern.
Informed written consent was obtained from the par-
ents of all babies. Thorough Ear, nose, and throat exam-
ination done before doing Transient evoked Otoacoustic
emission (TEOAE) that includes looking at the morpho-
logical abnormalities of the external ear. These new-
borns were screened for hearing impairment using the
following test protocols.
 Transient evoked Otoacoustic emission (TEOAE)
was employed as the first stage of screening by the
age of 1–3 days.
 Auditory brain stem response audiometry (AABR)
was performed at the age of three months for
confirming the hearing loss if the neonates failed the
TEOAE screening.
Children who had normal AABR were declared as eco-
logically sound & no further evaluation was suggested to
these children.
All neonates were screened with TEOAE testing in a
quiet room adjacent to the NICU. Otoread TEOAE
screeners (Interacoustic Ltd., Assens, Denmark) was used
for testing. The TEOAE was done by an audiologist who
was trained in doing the TEOAE and this test was done
free of cost. The Quick screen mode was used with a spe-
cially designed “stop” protocol that forced discontinuation
of the protocol when “pass” criteria was met. The timing
window was 12.5 milliseconds, and clicks were delivered
at a rate of 80 per second. Stimuli consisted of standard
transient clicks at 70 to 88 dB pSPL.
Otoacoustic emissions were judged to be present and
an ear to have “pass” when signal-to-noise ratio was at
least 3 dB in at least three of four frequency bands
(1000, 2000, 3000, and 4000 Hz). A minimum of 60 suc-
cessful sweeps was achieved in the test to be considered
valid. Screening continued until passing criteria were
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10 min. If a baby failed an initial screen, it was repeated
immediately after an effort to troubleshoot i.e. improve
probe fit, clean probe contaminated by dust, decrease
ambient noise, or change site of testing, calming baby by
swaddling, rocking, and eating. An acceptable screen
was done but once for each ear.
Follow-up testing consisted of AABR testing that was
performed under conditions of natural sleep using an Evo-
matic 4000 evoked potential unit (Medtronic, Minneapolis,
MN), a standard Ag/AgCl electrode applied on the fore-
head and each mastoid, and pediatric insert earphones
coupled to Etymotic ER3A stimulators (Etymotic Research,
Elk Grove, IL). The AABR was done by a trained audiolo-
gist and was done free of cost. Stimuli consisted of 100-
millisecond rarefaction clicks and tone pips presented at a
rate of 25 per second for at least 1000 presentations with
alternating triggering to permit both ears to be examined
simultaneously. Our cutoff values of normal were 23 to
26 dB for observable wave V for clicks and 30 dB NHL for
tone pips.
For babies who failed the initial TEOAE screening, the
mother, & relatives were contacted in person and coun-
selled as to the significance of a broken screen (i.e. sug-
gested need for further evaluation, not diagnosis of
hearing loss). These neonates’ parents were also con-
tacted in between for giving them a reminder for AABR
and on the day of examination, they were contacted in
personnel to get the test done.
Auditory brain stem response audiometry was used to
confirm the hearing loss if the neonates failed the
TEOAE screening at the age of 3 months.
For infants proven to suffer substantial hearing loss in
one or both ears, were referred to an Ear, nose, and
throat specialist for further evaluation & rehabilitation.Table 1 Table showing demographics of the population
-gestational age, birth weight, gender stratification in the with
and without risk factor groups
Distribution of total study population according to association of risk factor
Without risk factor With risk factor
Gestational age
<30 weeks 8 10
30–33 6/7 weeks 8 20Statistical analysis
All the patient data were entered into Microsoft excel
sheets. The Statistical Package for the Social Sciences
(SPSS) software version 16 for Windows was used for
data analysis. Student’s t test and Chi-square test were
used for data analysis. A p value less than 0.05 was con-
sidered significant.34–36 6/7 weeks 32 29





<1.5 kg 7 8
1.5–2.49 kg 53 54
>2.5 kg 188 105Results
In the present study, we have performed the initial
screening of 415 newborn by TEOAE, only 22 babies
had abnormal results. These 22 babies were further eval-
uated by AABR at age of 3 months. AABR showed 18
babies with confirmed significant hearing loss. Out of
the 22 babies with abnormal results, 16 babies were in
with any risk factor group and remaining babies were in
without any risk factor group.The demographic data of the study population, includ-
ing gestational age, birth weight, gender stratification in
with, and without risk factor groups are summarized in
Table 1. During the study period neonates with sus-
pected sepsis or clinical sepsis received cefotaxime and
amikacin as a first line empirical antibiotic therapy. The
newborn with asphyxial encephalopathy with sepsis,
nephrotoxic drugs were avoided. The antibiotics were
discontinued within 48 h if cultures were sterile. The
second line of antibiotics was piperacillin tazobactum or
Cefepime and antibiotics were changed as per the sensi-
tivity pattern of the microorganism. In neonates with
renal failure drug dose adjustment was performed.
Out of the 415 newborns screened with TEOAE test
22 (5.68 %) babies had abnormal screen either in single
or both ears. Out of total 22 abnormal TEOAE cases, 18
(81.82 %) cases were taking in significant hearing loss
with AABR while four (18.2 %) cases had normal AABR
(Fig. 1).
The comparison of various risk factors between nor-
mal AABR and abnormal AABR shows that Apgar score
at 5 min less than five, NICU admission, the presence of
fetal distress, presence of meconium stained amniotic
fluid are significantly important predictors for hearing
loss (Table 2). The risk stratification of the various fac-
tors in the study population has been depicted in the pie
diagram (Fig. 2).
Maternal fever was present in only 1 % patients ante-
natally and they all had normal hearing, while rash was
present in only 0.3 % of subjects and they also had no
significant hearing loss. Blood transfusion history was
present in total four patients and out of them three had
normal hearing screening and remaining one had signifi-
cant hearing loss. APH was present in 12 patients out of
Pass TEOAE 393(94.7%) Abnormal TEOAE 22 (5.3%) 
No. of newborn screened (415) 
with TEOAE 
Significant hearing loss 18 
(81.82%) Normal hearing 4 (18.18%) 
22 cases with abnormal 
TEOAE evaluated with 
AABR 
Fig. 1 Flow diagram with distribution of cases screened by TEOAE and cases with abnormal TEOAE evaluated with AABR
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cant hearing loss (Table 3).
The working cost for the institute for TEOAE was 250
Indian rupees (4 US dollars) and for AABR was 1300 In-
dian rupees (21 US dollars). The parents were not billed
for either of the probes.
Discussion
In our survey, among 415 of the total newborns
screened 94.7 % (393) cases passed on TEOAE while
5.3 % [19] cases were referred for initial screening at
birth.Table 2 Table comparing various risk factors associated with hearin
Normal hearing
Mean gestational age (weeks) 36.93 ± 2.41
Birth weight (kg) 2.667 ± 0.50
Male gender 221
Vaginal delivery 283
Apgar score at 5 min less than five 10
NICU admission 137
Fetal distress 73
Meconium stained amniotic fluid 28
Family history 15
Maternal age (years) 24.99 ± 3.3Nagapoornima et al. conducted a similar study in India
and screened a total of 1769 infants (1490: Not at risk;
279: At risk) & reported that 10 babies were having a hear-
ing impairment [20]. The high incidence of hearing im-
pairment seen in our study population could be explained
because of neonatal population with different geographical
area and also because of different maternal antenatal risk
factors. There can be also some unseen environmental
and genetic and epigenetic factors responsible for the high
incidence of hearing impairment in our studies.
John et al. conducted study in Christian Medical College
(C.M.C.) Vellore and evaluated 500 newborns and foundg loss in BERA positive cases
Hearing loss P value
36.71 ± 2.17 0.051













1 1 1 1 3 1
No risk factor Fetal distress Meconium stained Amniotic fluid
Family history of Hearing loss Apgar score less than 5 at 5 minutes Maternal fever
Maternal Rash Maternal Jaundice Maternal blood transfusion
Positive Maternal TORCH profile Antepartum Hemorrhage Others
Fig. 2 Pie diagram showing the risk factor stratification in the study population
Table 3 Distribution of cases according to antenatal history in relation to significant hearing loss
Antenatal history Significant hearing loss χ2 P
Absent Present Total
Fever No 383 (99.0 %) 18 (100.0 %) 401 (99.0 %) 0.188 0.883
Yes 4 (1.0 %) 0 4 (1.0 %)
Rash No 386 (99.7 %) 18 (100.0 %) 404 (99.8 %) 0.047 0.956
Yes 1 (0.3 %) 0 1 (0.2 %)
Jaundice No 383 (99.0 %) 17 (94.4 %) 400 (98.8 %) 2.844 0.089
Yes 4 (1.0 %) 1 (5.6 %) 5 (1.2 %)
Blood Transfusion No 384 (99.2 %) 17 (94.4 %) 401 (99.0 %) 4.019 0.045
Yes 3 (0.8 %) 1 (5.6 %) 4 (1.0 %)
Leaking per-vaginum No 375 (96.9 %) 17 (94.4 %) 392 (96.8 %) 0.334 0.564
Yes 12 (3.1 %) 1 (5.6 %) 13 (3.2 %)
Offending drug intake No 385 (99.5 %) 18 (100.0 %) 403 (99.5 %) 0.093 0.954
Yes 2 (0.5 %) 0 2 (0.5 %)
Radiation exposure No 387 (100 %) 18 (100.0 %) 405 (100.0 %) - -
Yes 0 0 0
Other No 384 (99.2 %) 18 (100.0 %) 402 (99.3 %) 0.141 0.987
Yes 3 (0.8 %) 0 3 (0.7 %)
Drug addiction No 382 (98.7 %) 17 (94.4 %) 399 (98.5 %) 2.142 0.143
Yes 5 (1.3 %) 1 (5.6 %) 6 (1.5 %)
Antenatal clinics attended No 98 (25.3 %) 5 (27.8 %) 103 (25.4 %) 0.055 0.815
Yes 289 (74.7 %) 13 (72.2 %) 302 (74.6 %)
Maternal TORCH profile No 386 (99.7 %) 18 (100.0 %) 404 (99.8 %) 0.047 0.829
Yes 1 (0.3 %) 0 1 (0.2 %)
Pre-eclampsia No 374 (96.6 %) 18 (100.0 %) 392 (96.8 %) 0.625 0.429
Yes 13 (3.4 %) 0 13 (3.2 %)
Antepartum hemorrhage No 377 (97.4 %) 16 (88.9 %) 393 (97.0 %) 4.350 0.037
Yes 10 (2.6 %) 2 (11.1 %) 12 (3.0 %)
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are quite comparable to our study. At the second stage
screening on 32 (6.4 %) cases by Distortion Product Oto-
acoustic Emission DPOAE, eight (25 %) were extended to
sustain a negative response [21] and similarly in our study
four neonates had normal AABR in follow up.
Thomson et al. in their study of newborn screening,
included 67,261 newborn from different states and 8.2 %
mothers of babies were from 11–19 years age group
while 23.1 % were from 20–25 years & 67.5 % mothers
were a 25 + age group [22]. In our study case for max-
imum cases coming from 21–25 years age group was
likely due to lower age for matrimony in our region as
compared to the western world. We found no link be-
tween maternal age and hearing loss.
In subject done by John et al. [21], they reported that
5.2 % of cases of failed hearing screening by DOAE were
from the birth weight less than 1500 g. Low birth weight
is also included as a risk factor for hearing impairment in
JCIH 2000 criteria [18]. A lower rate of hearing abnormal-
ities in low birth weight in our subject population can be
explained by either small sample size or high mortality in
babies of low birth weight in our population. The screen-
ing should be a part of all neonates irrespective of weight,
although the smallest, and tiniest neonates require AABR
as a primary modality, but using only weight as a criteria
is not advisable as full term neonates without any risk fac-
tors can also have hearing abnormalities.
Nagapoornima et al. [20] recorded that out of total
eight cases screened with a family story of childhood
sensorineural hearing loss two (25 %) cases were set up
to cause hearing impairment. In our study, out of 18
cases of hearing loss, 94 % [17] cases had no family his-
tory of significant childhood hearing loss in any sibling
of the child. Family history of hearing loss was present
in 16 (3.8 %) children and out of these only one case
had hearing handicap. This shows that although the
family history is recognized as an independent risk factor
for hearing loss but the neonates who don’t have any
family history are also prone to have hearing abnormal-
ities hence showing the importance of universal new-
born screening of all neonates irrespective of family
history of hearing loss.
John et al. [21] showed that a family history of hearing
loss was present in seven cases out of 500 (1.4 %) [5].
This high level of hearing loss may be due to deficiency
of awareness in our region & less access to health care
services.
In our study, most of the antenatal risk factor for hearing
loss were found non-significant except the history of ante-
partum hemorrhage and history of antenatal blood transfu-
sion in the mother. The apparent cause of these antenatal
risk factors associated with hearing loss may be due to
intrauterine distress to fetus followed by birth asphyxia.In our study, we concluded that the method of delivery
does not play a significant role on newborn hearing
impairment.
Out of the 18 neonates with significant hearing impair-
ment nine cases where having the antenatal sign of fetal
distress in the form of either meconium stained liquor,
bradycardia, or tachycardia. When comparing these data,
the difference was statistically significant (p < 0.01). This
could be explained because signs of fetal distress like
meconium stained liquor, bradycardia, or tachycardia indi-
cates fetal hypoxia, which may lead to damage to cochlear
cells and neuronal pathway leading to more significant
hearing abnormality. These findings also strengthen the
view that these neonates with perinatal asphyxia need to
be screened for hearing assessment.
In the present study, 16.7 % [3] cases out of 18 cases
of significant hearing loss were found to have Apgar
score ≤5. This was strongly associated risk factor for
neonatal hearing loss as fetal hypoxia can damage neo-
nates hearing system and lead to AABR abnormality.
Similar outcomes were likewise received in the survey
performed by Thomson et al. [21] on newborn screen-
ing. In his study 39 (1.2 %) babies of apgar ≤5 were
found to cause failure of hearing screening. Low Apgar
score is also included as a risk factor for hearing impair-
ment in JCIH 2000 criteria [18]. So our study confirms it
as associated risk factor.
According to JCIH 2000 criteria [18] an illness or condi-
tion requiring admission of 24 h or more to NICU has
termed as a risk factor for hearing impairment. Our study
confirms the same finding. This could be because the sick
neonates are exposed to various ototoxic drugs or hypoxia,
which increases the chances of hearing loss. The results
also tell that although the sick neonates are more likely to
have a higher incidence of hearing abnormalities, but the
normal neonates with no postnatal sickness or risk factors
can have hearing abnormalities, hence again highlighting
the need for universal screening.
In our experience from a developing country, we en-
countered few difficulties for newborn screening. The
availability of a trained audiologist and the cost are im-
portant issues. However, both OAE and AABR are paid
by the institution in the majority of places, hence all par-
ents from the low income and low middle income coun-
tries will not be able to get their newborn infant
screened. As both OAE and AABR were free to our pa-
tients could be one of the reason for hundred percent
follow up of all infants. All these problems can be over-
come if the government makes hearing screening com-
pulsory, and free of cost, and many more audiologists
are trained for performing newborn screens. Though the
initial phase of screening implementation may be costly
because getting new screening machines, training new
audiologist, and setting up new rehabilitation centers,
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cost effective and will help in reducing the burden on
society because of hearing impairments.
In the nursery, the high risk neonates are more prone to
suffer hearing problems. In the various studies done it has
been shown that in these neonates AABR when compared
with OAE has better sensitivity and specificity which high-
lights that in these neonates AABR should be a primary
screening modality and in normal neonates OAE can be
taken as a primary modality of screening [19, 23].
Hence the results of our study show that all neonates
having a turbulent course in nursery and various risk fac-
tors, needs to be screened for hearing assessment and neo-
nates with the abnormal OAE need to be followed up.
Universal screening of hearing should be done as neonates
with no risk factors can also have abnormal hearing as
seen in our study and it can delay the diagnosis of hearing
impairment and also intervention for rehabilitation.
The limitation of our study includes small sample size,
and our inability to evaluate all the risk factors of JCIH
criteria. The strong point of our study includes hundred
percent follow up of all the newborns who had abnormal
OAE and all these neonates had AABR done. This was
possible as we educated all parents regarding the conse-
quences of impaired hearingand maintained regular con-
tact with them.
Conclusion
Late identification of hearing loss presents a significant
public health concern. However, without screening, chil-
dren with hearing loss are usually not identified until
2 years of age, which results in significant delays in voice
communication, language communication, social, cogni-
tive, and emotional development. In contrast, early rec-
ognition, and intervention prior to 6 months of historic
period has a significant positive impact on development.
Hence, there is an urgent need to incorporate univer-
sal neonatal hearing screening in all the neonatal health
care facilities in India. While studying the facts like in-
frastructure limitations of our rural area where basic
needs are deficient, there is a demand to employ cost-
effective behavioural observation methods using cali-
brated noise making toys to screen all newborn infants.
Further prospective studies on a larger sample size are
required to study the association of hearing impairment
with various congenital syndromes and antenatal, peri-
natal, postnatal & demographic factors.
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